Unitree Robotics has won regulatory clearance from the China Securities Regulatory Commission to list on Shanghai’s STAR Market, opening the way for the Hangzhou based robot maker to raise about 4.202 billion yuan (roughly $619 million) in what would be the first public offering by a humanoid robot company. The regulator approved the registration in a record 104 days, the fastest review since the STAR Market introduced its pre review mechanism, according to Caixin Global. The deal implies an overall valuation near 42 billion yuan (roughly $6.2 billion) and would make Unitree the first publicly traded maker of humanoid robots.
The CSRC published the approval on July 2, 2026, granting Unitree Technology registration for its offering, in a decision Caixin reported as clearing the way for what markets are already calling the first humanoid robot stock. The company plans to issue at least about 40.45 million shares to raise around 4.202 billion yuan. Based on a public float of no less than 10 percent, that pricing implies an overall valuation near 42 billion yuan. Those approval based figures sit well below the far larger numbers that circulated earlier when the market was still guessing at Unitree’s worth.
The speed is its own headline. Unitree took only 104 days from application acceptance to registration approval, described as the fastest review since the STAR Market introduced its pre review mechanism. For a Chinese regulator that has often let technology listings sit for many months, that pace reads as a signal. Beijing has folded embodied AI into its broader ambitions for advanced manufacturing, and Unitree has become one of the most visible names in that push, from its low cost quadrupeds to humanoid units that have appeared everywhere from research labs to televised events. Fast tracking its listing places a flagship of the sector onto public markets while the enthusiasm is still hot. It also gives China a homegrown reference point for valuing embodied AI, a category the United States has so far kept largely inside private labs and carmakers. Whoever prints the first public price on a humanoid robot company sets an anchor everyone else will argue with.
Then comes the part that keeps this from being a simple victory lap. Reporting on Unitree’s latest results describes a company whose growth is decelerating even as its profile rises. First quarter revenue growth slowed to about 68 percent year over year, still a strong figure in absolute terms but a sharp step down from the much faster expansion the company had posted earlier. Net profit, meanwhile, roughly halved year over year. A business that was compounding at a blistering rate is now growing more slowly and earning less, right as it asks public investors to buy in.
Unitree’s own prospectus does not hide the pressure. It warns of price competition, and it names the source directly. Tesla, with its Optimus program, and domestic automakers moving into robotics are crowding into the same space Unitree helped popularize. That matters because the humanoid category has almost no established pricing, thin volumes, and a crowd of well funded entrants willing to absorb losses to win position. The companies that mastered manufacturing electric cars now see robots as the next platform, and they bring balance sheets Unitree cannot match. A warning about price competition from that group is not boilerplate risk language. It is a description of the market Unitree is about to be judged in as a listed company.
So the read here is genuinely two sided, and it should stay that way. On one side is a real milestone. A record fast approval, a concrete valuation, and the symbolic weight of the first humanoid robot maker crossing from private hype into public accountability. That transition forces disclosure, quarterly scrutiny, and a market price that anyone can see, which is healthy for a sector long measured in promises. On the other side are fundamentals that are cooling at exactly the wrong moment for a narrative built on endless acceleration. Slower growth and halved profit do not sink the story, but they puncture the idea that humanoid robotics is already a proven business rather than an expensive bet.
The listing will not settle that debate. It will price it. Once Unitree trades, the market will assign a number to how much of the robot boom is durable demand and how much is momentum. If the shares hold near that 42 billion yuan (roughly $6.2 billion) implied valuation, it suggests investors are willing to look past a soft quarter toward a larger platform. If they slide, it signals that the reality check landed. Either way, the era of judging humanoid robotics purely by demo reels is ending. From here, Unitree gets graded on revenue, margins, and whether it can defend its lead against rivals with far deeper pockets. That is a harder test than winning applause on a stage, and it is the one that public markets exist to run.